The Impact of COVID-19 on Hypertrophic Cardiomyopathy Patients: Causes, Predictors, and Outcomes of 30-Day Readmission

Presenter/Author Information

Zaid Abood MD, Cardiovascular and Thoracic Services, Aurora St. Luke’s Medical Center, Advocate HealthFollow
M Fuad Jan MBBS, MD, Interventional Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
Arshad Jahangir MD, Electrophysiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow
A Jamil Tajik MD, Cardiology, Aurora St. Luke’s Medical Center, Advocate HealthFollow

Recommended Citation

Abood Z, Jan MF, Jahangir A, Tajik AJ. The Impact of COVID-19 on Hypertrophic Cardiomyopathy Patients: Causes, Predictors, and Outcomes of 30-Day Readmission. J Patient Cent Res Rev. 2024;11:241. doi: 10.17294/2330-0698.2137

Affiliations

Aurora Cardiovascular and Thoracic Services, Aurora St. Luke’s Medical Center

Presentation Notes

Oral presentation at Scientific Day; May 22, 2024; Milwaukee, WI. https://institutionalrepository.aah.org/sciday/2024/judged1/4/

Document Type

Abstract